Description
In general, large pharmaceutical companies favor adopting functional service provider (FSP) models over full-service outsourcing across their clinical and research and development (R&D) operations. FSPs allow for greater oversight and can offer better outcomes regarding accelerated delivery and higher quality data. Can smaller companies benefit from working with a contract research organization (CRO) through an FSP model? During this webinar, participants will delve into the explorative realm of FSP models, particularly how to curate them for mid-sized companies to elevate their clinical trial performance.